Tanya has been in the pharmaceutical industry for over 20 years supporting multiple disease states and products in various capacities. The last 15 years has been focused on Market Access. The past five years has been on educating employers about the impact of Obesity as a disease in the workplace. Currently, she is focused on the impact of mental health/behavioral health and how Digital Therapeutics can be used as autonomous and/or adjunct tool for individuals with Major Depressive Disorder, Alcohol Consumption Management and Opioid Use Disorder. She is passionate about driving awareness to empower patients, clinicians, and payers to access intelligent tools to help address these major issues.